title: Re: five-day oral etoposide treatment for advanced small-cell lung cancer: randomized comparison with intravenous chemotherapy.
authors.forename: P
authors.initials: P
authors.lastname: Pfeiffer
authors.forename: C
authors.initials: C
authors.lastname: Rytter
authors.forename: E L
authors.initials: EL
authors.lastname: Madsen
authors.forename: K
authors.initials: K
authors.lastname: Moeholt
authors.forename: O
authors.initials: O
authors.lastname: Hansen
authors.forename: S
authors.initials: S
authors.lastname: Bentzen
authors.forename: T
authors.initials: T
authors.lastname: Palshof
authors.forename: C
authors.initials: C
authors.lastname: Rose
mesh_terms: D000284:Administration, Oral; D000368:Aged; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D018288:Carcinoma, Small Cell / Q000188:drug therapy*; D004334:Drug Administration Schedule; D005047:Etoposide / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007262:Infusions, Intravenous; D008175:Lung Neoplasms / Q000188:drug therapy*; D008875:Middle Aged; D010166:Palliative Care; D016019:Survival Analysis; D016896:Treatment Outcome
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D005047:Etoposide